{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:00:17Z","timestamp":1744221617473},"reference-count":5,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,10]]},"DOI":"10.7759\/cureus.50268","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T13:40:27Z","timestamp":1702215627000},"source":"Crossref","is-referenced-by-count":1,"title":["Fifth-Generation Cephalosporins Is Not Spared From Drug-Induced Liver Injury"],"prefix":"10.7759","author":[{"given":"Monish A","family":"Sheth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1240002","article-title":"Epidemiology of idiosyncratic drug-induced liver injury","volume":"29","author":"Bell LN","year":"2009","unstructured":"Bell LN, Chalasani N. Epidemiology of idiosyncratic drug-induced liver injury. Semin Liver Dis. 2009, 29:337-47. 10.1055\/s-0029-1240002","journal-title":"Semin Liver Dis"},{"key":"ref2","article-title":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury","year":"2012","unstructured":"LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, 2012."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22177","article-title":"Acute liver failure: summary of a workshop","volume":"47","author":"Lee WM","year":"2008","unstructured":"Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008, 47:1401-15. 10.1002\/hep.22177","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.11.036","article-title":"Identification and characterization of cefazolin-induced liver injury","volume":"13","author":"Alqahtani SA","year":"2015","unstructured":"Alqahtani SA, Kleiner DE, Ghabril M, Gu J, Hoofnagle JH, Rockey DC. Identification and characterization of cefazolin-induced liver injury. Clin Gastroenterol Hepatol. 2015, 13:1328-36. 10.1016\/j.cgh.2014.11.036","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/08971900211015046","article-title":"A case-report of drug-induced mixed liver injury resulting from cefepime exposure","volume":"36","author":"Malhotra K","year":"2023","unstructured":"Malhotra K, Fazylov R, Friedman-Jakubovics M. A case-report of drug-induced mixed liver injury resulting from cefepime exposure. J Pharm Pract. 2023, 36:164-7. 10.1177\/08971900211015046","journal-title":"J Pharm Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/210194-fifth-generation-cephalosporins-is-not-spared-from-drug-induced-liver-injury","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:08:25Z","timestamp":1707509305000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/210194-fifth-generation-cephalosporins-is-not-spared-from-drug-induced-liver-injury"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,10]]},"references-count":5,"URL":"https:\/\/doi.org\/10.7759\/cureus.50268","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,10]]}}}